Frequently asked questions

RGCC’s tests are at the cutting-edge of medical science and are not currently offered by healthcare providers. Health providers, such as the NHS, are trialling genetic testing to diagnose and treat cancer. In the future, it is likely that genetic testing will be offered by all healthcare providers. At RGCC, we believe that everyone should be able to experience the benefits of personalised medicine. Our range of genetic tests is currently available in 23 countries through the RGCC Network of healthcare professionals. To find your nearest RGCC registered clinician, send us a message via our website.

Our methods are accredited by the International Organisation for Standardisation (ISO). Details of our certifications can be found on our website.

Yes. We take considerable care in protecting the patient’s identity throughout the process. We have strict data protection policies in place and adhere to all legislation, including GDPR.

We never use or resell your genetic information to third parties. The sample you provide to use is only used for the intended test.

Once the test has been completed, your sample will be stored for a time period of six months, just in case any further testing will be required.

Due to various factors, we are unable to provide a breakdown of costs but recommend that you speak with your clinician or healthcare provider. We will work with your chosen individual healthcare provider to provide an accurate cost for your test. Our prices are transparent and fixed, and you will not be liable for additional transportation or processing costs.

Yes. The total cost includes the test kit, shipping fees, processing the test and the preparation of your results.

Tests will be processed and the results made available within 14 working days.

We collaborate with leading clinicians and healthcare providers across the globe to help share knowledge and improve outcomes for cancer patients. The RGCC Network are approved providers of RGCC genetic tests. Working closely with the RGCC Network, we provide personalised cancer genetic tests that accurately discover, analyse and screen the disease at every stage. Using this vital information, our healthcare partners are able to make better informed decisions and enhance patient care.

You will need to sign a declaration form called a non-dangerous goods document. This is a safety form to guarantee that the sample you are sending is not dangerous, harmful or a potential contaminant to public health.

All over the world. Dedicated RGCC branch offices support doctors in 23 countries, including the USA, India, the UK, Japan and Australia, providing information, advice and resources that can be shared across your practice and directly with patients. Network members gain exclusive access to articles, webinars and research papers written by our world-leading scientists to help you increase your understanding and provide a deeper level of care.

You will need a document called an audit UN3373. This document indicates the origin of the sample, and gives the courier packaging and shipping precautions. It is required to import the biological substances in the samples to our facility in Greece.